OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis
Nanyang Liu, Jiahui Sun, Xiyuan Wang, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 4, pp. 1775-1782
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2022) Vol. 145, Iss. 8
Open Access | Times Cited: 4227

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2023) Vol. 147, Iss. 8
Open Access | Times Cited: 4163

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 856

Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Gill Livingston, Jonathan Huntley, Kathy Liu, et al.
The Lancet (2024) Vol. 404, Iss. 10452, pp. 572-628
Closed Access | Times Cited: 480

Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative
Tellen D. Bennett, Richard A. Moffitt, Janos Hajagos, et al.
JAMA Network Open (2021) Vol. 4, Iss. 7, pp. e2116901-e2116901
Open Access | Times Cited: 211

Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries
Guillaume Fond, Katlyn Nemani, Damien Etchecopar‐Etchart, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 11, pp. 1208-1208
Open Access | Times Cited: 198

Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
Marina Treskova, Laura Haas, Sarah Reda, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 154

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 69

Dementia wellbeing and COVID‐19: Review and expert consensus on current research and knowledge gaps
Kathy Liu, Robert Howard, Sube Banerjee, et al.
International Journal of Geriatric Psychiatry (2021) Vol. 36, Iss. 11, pp. 1597-1639
Open Access | Times Cited: 73

The National COVID Cohort Collaborative: Clinical Characterization and Early Severity Prediction
Tellen D. Bennett, Richard A. Moffitt, Janos Hajagos, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 62

Effects of COVID-19 on cognition and brain health
Sijia Zhao, Sofia Toniolo, Adam Hampshire, et al.
Trends in Cognitive Sciences (2023) Vol. 27, Iss. 11, pp. 1053-1067
Open Access | Times Cited: 38

State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease
Elizabeth M. Rhea, Manon Leclerc, Hussein N. Yassine, et al.
Aging and Disease (2023)
Open Access | Times Cited: 35

Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?
Ewa Rudnicka-Drożak, Paulina Drożak, Grzegorz Mizerski, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 2146-2146
Open Access | Times Cited: 32

Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
Pei Huang, Linyuan Zhang, Yuyan Tan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 29

Key components of post-diagnostic support for people with dementia and their carers: A qualitative study
Claire Bamford, Alison Wheatley, Greta Brunskill, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0260506-e0260506
Open Access | Times Cited: 51

Dementia as a mortality predictor among older adults with COVID-19: A systematic review and meta-analysis of observational study
Ita Daryanti Saragih, Ice Septriani Saragih, Sakti Oktaria Batubara, et al.
Geriatric Nursing (2021) Vol. 42, Iss. 5, pp. 1230-1239
Open Access | Times Cited: 42

SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
Paul Lingor, Antonia F. Demleitner, Andreas Wolff, et al.
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1155-1167
Open Access | Times Cited: 29

The impact of social isolation from COVID-19-related public health measures on cognitive function and mental health among older adults: A systematic review and meta-analysis
Prapichaya Prommas, Kaung Suu Lwin, Yi Chi Chen, et al.
Ageing Research Reviews (2022) Vol. 85, pp. 101839-101839
Open Access | Times Cited: 28

Dementia Care Is Widespread In US Nursing Homes; Facilities With The Most Dementia Patients May Offer Better Care
Dana B. Mukamel, Debra Saliba, Heather Ladd, et al.
Health Affairs (2023) Vol. 42, Iss. 6, pp. 795-803
Open Access | Times Cited: 19

Molecular cross-talk between long COVID-19 and Alzheimer’s disease
Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2885-2899
Open Access | Times Cited: 7

Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again?
Nian Xiong, Martin Schiller, Jingwen Li, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 38

Dementia Clinical Care in Relation to COVID-19
Angelo Bianchetti, Renzo Rozzini, Luca Bianchetti, et al.
Current Treatment Options in Neurology (2022) Vol. 24, Iss. 1, pp. 1-15
Open Access | Times Cited: 25

SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses
Muhannad Smadi, Melina Kaburis, Youval Schnapper, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 2, pp. 348-361
Open Access | Times Cited: 15

Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based study
Irene Visos‐Varela, Maruxa Zapata‐Cachafeiro, María Piñeiro‐Lamas, et al.
European Neuropsychopharmacology (2023) Vol. 71, pp. 96-108
Open Access | Times Cited: 13

Page 1 - Next Page

Scroll to top